PRESS RELEASE 2025
US Press Releases > PRESS RELEASE 2025
-
Ferring Highlights Commitment to C. Diff Infection Community on the Second Anniversary of the Launch of REBYOTA® (fecal microbiota, live – jslm)
FDA approved to prevent recurrent C. difficile infection (rCDI), REBYOTA is widely available with a strong drug supply and dedicated manufacturing facility Since launch, Ferring created REBYOTA @ Home to help patients with rCDI across the U.S. receive treatment at home as well as health care sett...